Monoamine

Monoamines are a family of signalling molecules that share a common chemical structure: an aromatic ring joined to a short carbon chain ending in a single amine group. The brain's three principal monoamine neurotransmitters — serotonin, dopamine, and norepinephrine — regulate a wide range of functions, including mood, motivation, attention, sleep, appetite, and voluntary movement.

The class also includes epinephrine, histamine, and a range of trace amines. Together they form the chemical infrastructure that most psychoactive substances — stimulants, antidepressants, and classical psychedelics alike — engage at some level, whether at their receptors, their transporters, or the enzymes that break them down.

How it works · its role

Each monoamine is synthesised from a dietary amino acid. Dopamine and norepinephrine are built from tyrosine; serotonin from tryptophan. Enzymes convert these precursors into the finished neurotransmitter, which is then packaged into small vesicles and released into the synapse when a neuron fires.

Once in the synapse, monoamines are cleared primarily by two routes. Dedicated transporters — DAT for dopamine, NET for norepinephrine, SERT for serotonin — pull the molecule back into the releasing neuron, ending the signal. Any remaining monoamine is broken down by monoamine oxidase (MAO), or in the case of catecholamines also by catechol-O-methyltransferase (COMT).

This transport-and-degradation system is the principal target of most psychoactive drugs. Slowing it, reversing it, or bypassing it entirely shifts how much monoamine is available at the synapse — and with it, mood, arousal, and perception.

Relevance to substances & effects

Because monoamines underlie mood, reward, and arousal, they are the primary site of action for many of the most widely used psychoactive substances.

Stimulants such as amphetamines and cocaine raise dopamine and norepinephrine levels sharply — amphetamines by forcing the transporters to run in reverse; cocaine by blocking them outright. MDMA produces a more serotonin-dominant surge across all three systems, which accounts for its distinct emotional character relative to other stimulants. Many antidepressants target the same transporters, but act more selectively and over a longer timescale.

Classical psychedelics — LSD, psilocin, mescaline — engage the monoamine system differently. Rather than altering monoamine availability, they act directly at serotonin receptors, particularly 5-HT₂A, producing perceptual and cognitive changes through receptor activation alone.

Understanding which component of the monoamine system a substance acts on helps explain why drugs in the same broad category can feel, interact, and risk-profile so differently from one another.